EP1877058A4 - USE OF PHYCOTOXINES IN VETERINARY MEDICINE APPLICATIONS - Google Patents

USE OF PHYCOTOXINES IN VETERINARY MEDICINE APPLICATIONS

Info

Publication number
EP1877058A4
EP1877058A4 EP06752321A EP06752321A EP1877058A4 EP 1877058 A4 EP1877058 A4 EP 1877058A4 EP 06752321 A EP06752321 A EP 06752321A EP 06752321 A EP06752321 A EP 06752321A EP 1877058 A4 EP1877058 A4 EP 1877058A4
Authority
EP
European Patent Office
Prior art keywords
phycotoxins
veterinary applications
veterinary
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06752321A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1877058A2 (en
Inventor
Nestor Antonio Lagos Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phytotox Ltd
Original Assignee
Phytotox Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phytotox Ltd filed Critical Phytotox Ltd
Publication of EP1877058A2 publication Critical patent/EP1877058A2/en
Publication of EP1877058A4 publication Critical patent/EP1877058A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EP06752321A 2005-05-05 2006-05-05 USE OF PHYCOTOXINES IN VETERINARY MEDICINE APPLICATIONS Withdrawn EP1877058A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67793305P 2005-05-05 2005-05-05
PCT/US2006/017449 WO2006119499A2 (en) 2005-05-05 2006-05-05 Use of phycotoxins in veterinary applications

Publications (2)

Publication Number Publication Date
EP1877058A2 EP1877058A2 (en) 2008-01-16
EP1877058A4 true EP1877058A4 (en) 2008-06-25

Family

ID=37308745

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06752321A Withdrawn EP1877058A4 (en) 2005-05-05 2006-05-05 USE OF PHYCOTOXINES IN VETERINARY MEDICINE APPLICATIONS

Country Status (5)

Country Link
EP (1) EP1877058A4 (ja)
JP (1) JP2008540452A (ja)
AU (1) AU2006243644A1 (ja)
CA (1) CA2606315A1 (ja)
WO (1) WO2006119499A2 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200012833A (ko) * 2017-03-29 2020-02-05 사이트원 테라퓨틱스, 인코포레이티드 통증 치료용 11,13-개질된 색시톡신

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024419A1 (en) * 1998-10-27 2000-05-04 Mayo Foundation For Medical Education And Research Methods for enhancing wound healing
WO2005110417A1 (en) * 2004-05-07 2005-11-24 Phytotox Limited Phycotoxins and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04004543A (es) * 2001-11-15 2005-03-31 Micro Algae Corp Composiciones farmaceuticas que contienen 3,4-propinoperhidropurinas y sus usos para el bloqueo de la transmision neuronal.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024419A1 (en) * 1998-10-27 2000-05-04 Mayo Foundation For Medical Education And Research Methods for enhancing wound healing
WO2005110417A1 (en) * 2004-05-07 2005-11-24 Phytotox Limited Phycotoxins and uses thereof
WO2005110275A1 (en) * 2004-05-07 2005-11-24 Phytotox Limited Methods of treating wounds with gonyautoxins

Also Published As

Publication number Publication date
JP2008540452A (ja) 2008-11-20
WO2006119499A2 (en) 2006-11-09
EP1877058A2 (en) 2008-01-16
AU2006243644A1 (en) 2006-11-09
CA2606315A1 (en) 2006-11-09
WO2006119499A3 (en) 2006-12-28

Similar Documents

Publication Publication Date Title
TWI561237B (en) Substituted dihydropyrazolones and their use
GB0512940D0 (en) Compounds and their use
ZA200810323B (en) Fkbp-l and uses thereof
IL189609A0 (en) 4-substituted pyrrolidin-2-ones and their use
HK1208000A1 (en) Thioninium compounds and their use
LT2064327T (lt) Dbait ir jų panaudojimas
HK1119070A1 (en) Use of trans-clomiphene in the manufacture of medicines
ZA200707903B (en) Colourant compositions and their use
IL194899A0 (en) Amino-ethyl-amino-aryl (aeaa) compounds and their use
GB0520743D0 (en) Compounds and their use
EP1888560A4 (en) NOVEL DIPODAZINE COMPOUNDS AND THEIR APPLICATIONS
HK1133552A1 (en) Carboranylporphyrins and uses thereof
GB0611115D0 (en) Compounds and their use
IL189252A0 (en) Dihydroxyanthraquinones and their use
EP1921066A4 (en) PYRIDYLPHENOL COMPOUND AND USE THEREOF
GB0525093D0 (en) Veterinary composition
EP2069371A4 (en) ORGANO ARSENOXIDE COMPOUNDS AND THEIR USE
EP1845135A4 (en) COMPOSITION COMPOSED OF OXOCOAL SUBSTANCE AND USE THEREOF
GB0508991D0 (en) Veterinary composition
EP2133326A4 (en) NEW PSEUDOGLYCOLIPID AND ITS USE
IL192820A0 (en) Novel compounds and use thereof
GB0619611D0 (en) Compounds and their use
EP1877058A4 (en) USE OF PHYCOTOXINES IN VETERINARY MEDICINE APPLICATIONS
GB0521278D0 (en) Compounds and their use
GB0513176D0 (en) Compounds and their use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071102

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20080526

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/70 20060101ALI20080519BHEP

Ipc: A61P 21/02 20060101ALI20080519BHEP

Ipc: A61K 31/519 20060101AFI20080519BHEP

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20080919

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20091105